October 17-18, 2018 Ottawa, USA
The term “theranostics” was coined to define ongoing efforts in clinics to develop more specific, individualized therapies for various diseases, and to combine diagnostic and therapeutic capabilities into a single agent. The rationale arose from the fact that diseases, such as cancers, are immensely heterogeneous, and all existing treatments are effective for only limited patient subpopulations and at selective stages of disease development. The emergence of nanotechnology has offered an opportunity to draw diagnosis and therapy closer. Nanoparticle (NP)-based imaging and therapy have been investigated separately, and understanding of them has now evolved to a point enabling the birth of NP-based theranostics, which can be defined as nanoplatforms that can co-deliver therapeutic and imaging functions.
Journals related to Theranostic
Journal of Biomolecular Research & Therapeutics, Journal of Chemical Biology & Therapeutics, Journal of Pharmacokinetics & Experimental Therapeutics, Theranostics Journal Impact & Description, Introducing Theranostics Journal.